Genentech aren't looking for drug candidates, they're looking for a new approach to drug discovery. They have seen something in the technologies on offer which is of interest. On the basis of their past collaboration, Genentech have entered into the new agreement with eyes wide open.
- Forums
- ASX - By Stock
- PYC
- Genentech Revisited
PYC
pyc therapeutics limited
Add to My Watchlist
0.00%
!
$1.30

Genentech Revisited
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.30 |
Change
0.000(0.00%) |
Mkt cap ! $755.3M |
Open | High | Low | Value | Volume |
$1.30 | $1.31 | $1.29 | $441.6K | 340.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 1198 | $1.29 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.30 | 49014 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 1198 | 1.290 |
1 | 1567 | 1.285 |
1 | 7039 | 1.280 |
2 | 4010 | 1.275 |
2 | 2891 | 1.270 |
Price($) | Vol. | No. |
---|---|---|
1.300 | 49014 | 3 |
1.305 | 23838 | 2 |
1.310 | 44000 | 2 |
1.320 | 30891 | 2 |
1.325 | 9001 | 1 |
Last trade - 13.17pm 02/07/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
RAC
RACE ONCOLOGY LTD
Dr Pete Smith, Executive Chairman
Dr Pete Smith
Executive Chairman
SPONSORED BY The Market Online